Latest Pharma Deals Draw Counsel from Am Law Firms

AstraZeneca has agreed to buy the rights to respiratory drugs owned by Almirall for $2.1 billion, with Covington & Burling and British firm CMS Cameron McKenna. Meanwhile, Kirkland & Ellis and Sidley Austin are leading the way on Pfizer's acquisition of Baxter International's vaccine portfolio.

YOUR COMPLIMENTARY 15-DAY LAW.COM TRIAL HAS ENDED.
Subscribe now to continue reading →

To continue reading, upgrade and become a Law.com subscriber.
Get 2 MONTHS FREE when you sign up for a 12 month subscription.